Epigenomics Overview
- Year Founded
-
1998

- Status
-
Public
- Employees
-
63

- Stock Symbol
-
ECX

- Share Price
-
$1.20
- (As of Friday Closing)
Epigenomics General Information
Description
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.
Contact Information
Website
epigenomics.comCorporate Office
- Bertha-Benz-Straße 5
- 10557 Berlin
- Germany
Corporate Office
- Bertha-Benz-Straße 5
- 10557 Berlin
- Germany
Epigenomics Stock Performance
As of 14-Feb-2025, Epigenomics’s stock price is $1.20. Its current market cap is $1.05M with 875K shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.20 | $1.19 | $0.54 - $2.40 | $1.05M | 875K | 387.77 |
Epigenomics Financials Summary
As of 31-Dec-2023, Epigenomics has a trailing 12-month revenue of $5.46M.
In Thousands, USD |
TTM 31-Dec-2023 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | (1,723) | (1,723) | (7,137) | (18,138) |
Revenue | 5,461 | 5,461 | 510 | 7,334 |
EBITDA | (4,005) | (4,005) | (11,903) | (2,307) |
Net Income | (12,642) | (2,871) | ||
Total Assets | 14,198 | 14,198 | 17,000 | 27,924 |
Total Debt | 0 | 0 | 902 | 521 |
Epigenomics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Epigenomics Comparisons
Industry
Financing
Details
Epigenomics Competitors (41)
One of Epigenomics’s 41 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Agendia | Venture Capital-Backed | Irvine, CA | ||||
Foundation Medicine | Formerly VC-backed | Cambridge, MA | ||||
Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
Illumina | Formerly VC-backed | San Diego, CA | ||||
Exact Sciences | Formerly VC-backed | Madison, WI |
Epigenomics Patents
Epigenomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4185714-A1 | Methods for detecting liver cancer | Pending | 21-Jul-2020 | ||
CA-3161720-A1 | Methods for detecting colorectal cancer | Pending | 16-Dec-2019 | ||
EP-4077734-A1 | Methods for detecting colorectal cancer | Pending | 16-Dec-2019 | ||
US-20200299779-A1 | Methods for detecting head and neck cancer | Inactive | 13-Feb-2019 | ||
EP-3924737-A1 | Methylated genomic dna as a marker of head and neck cancer | Inactive | 13-Feb-2019 | C12Q1/6886 |
Epigenomics Signals
Epigenomics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Biotechnology
Subindustry
Rank
Percentile

Epigenomics FAQs
-
When was Epigenomics founded?
Epigenomics was founded in 1998.
-
Where is Epigenomics headquartered?
Epigenomics is headquartered in Berlin, Germany.
-
What is the size of Epigenomics?
Epigenomics has 63 total employees.
-
What industry is Epigenomics in?
Epigenomics’s primary industry is Diagnostic Equipment.
-
Is Epigenomics a private or public company?
Epigenomics is a Public company.
-
What is Epigenomics’s stock symbol?
The ticker symbol for Epigenomics is ECX.
-
What is the current stock price of Epigenomics?
As of 14-Feb-2025 the stock price of Epigenomics is $1.20.
-
What is the current market cap of Epigenomics?
The current market capitalization of Epigenomics is $1.05M.
-
What is Epigenomics’s current revenue?
The trailing twelve month revenue for Epigenomics is $5.46M.
-
Who are Epigenomics’s competitors?
Agendia, Foundation Medicine, Genomic Expression, Illumina, and Exact Sciences are some of the 41 competitors of Epigenomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »